載入...
Temsirolimus Is Highly Effective as Third-Line Treatment in Chromophobe Renal Cell Cancer
We report unexpectedly high efficacy of temsirolimus as third-line treatment in a patient with metastatic chromophobe renal cell carcinoma. After failure of two sequentially administered tyrosine kinase inhibitors, treatment with temsirolimus resulted in a prolonged partial remission of 14 months, a...
Na minha lista:
| Main Authors: | , , , , , , |
|---|---|
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
S. Karger AG
2011
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3082484/ https://ncbi.nlm.nih.gov/pubmed/21526001 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000323804 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|